All GLG News Analyses Filed Under: Business of Medicine

Are Health Courts the Last Best Chance for Bipartisan Reform?

September 11, 2009

Analysis by: GLG Expert Contributor

Analysis of:New Nationwide Poll Finds Most Americans Want Medical Malpractice System Changes as Part of Health Care Reform | www.philipkhoward.com

One of the few things which President Obama said in his Address on Health Care to a Joint Session of Congress this past week which brought Republicans to their feet was the offer of changing the current medical malpractice system as part of health care reform. To the extent that the President is still serious about attracting more than Senator Olympia Snowe (R-ME) to support an ultimate bill, he would be wise to include this is any final legislation coming out of the Joint Conference Committee.

GSK - Reddy's will it be a reality???

September 11, 2009

Analysis by: GLG Expert Contributor

Analysis of:Is Glaxo circling Dr Reddy's? | www.dnaindia.com

GSK has been a market leader in India and international markets for quite some time!!!While Dr. Reddy's is relatively new kid on the block compared to GSK. What GSK is actually after is Dr. Reddy's manufacturing plants and API facilities. GSK is looking to bring down is global production cost. India being an established contract manufacturing center fits into GSK's global plan quite well. 

HMO shares rise after Obama health reform speech

September 10, 2009

Analysis by: GLG Expert Contributor

Analysis of:HMO Shares Rise - Threat or Opportunity | www.reuters.com

New pushes into the individual market by Aetna and Cigna, along with United, Humana, Blue Cross, etc prove real opportunity to capture 45,000,000 - 85,000,000 uninsured lives. The big unknown is how Not For Profit enterprise will access capital for Surplus reserves less expensively than Federal plans. For any commercial carrier to compete in a sustainable way will require equal access to capital or the state will win everytime.

Role of CROs in Pharma industry

September 7, 2009

Analysis by: GLG Expert Contributor

Analysis of:China's CRO industry booms as pharma demand heats up | www.fiercebiotech.com

Any Pharma industry is driven by their CROs in their region.CROs open up new avenues in patients treatment.

John AnsellDirectorJohn Ansell Consultancy

Dainippon Sumitomo acquires a bridgehead and settles Sepracor's uncertain future

September 4, 2009

Analysis of:Dainippon Sumitomo Pharma to Acquire Sepracor for U.S. $23.00 Per Share in an All-Cash Tender Offer Valued at Approximately U.S. $2.6 Billion | www.pipelinereview.com

In acquiring Sepracor, Dainippon Sumitomo is gaining a modest-sized commercial bridgehead for marketing its products in North America, but one which by itself had an uncertain future. Dainippon Sumitomo will need to take action to stabilize a company which has been facing issues concerning its future sustainability.

Ranbaxy getting out of the bush!!!

September 4, 2009

Analysis by: GLG Expert Contributor

Analysis of:India's Ranbaxy to launch generic Rocaltrol in U.S. | www.reuters.com

Slowly and steadily we are seeing positive news trickle in from Ranbaxy!! This indicates that measures taken to put their house in order are finally showing results. The latest approval to market Rocaltrol for which Ranbaxy will be the 1st to launch the Generic version will be good addition to the bottom line. 1st Generic always has a good advantage in terms of market capturing abilities. With a 70 million market open to capture, getting 35 - 40 million in 18 - 24 months is not impossible. 

Physicians paid on Salary basis provide better quality of Health care services

September 3, 2009

Analysis by: GLG Expert Contributor

Analysis of:Mass. Panel Backs Radical Shift in Health Payment | www.nytimes.com

When physicians are paid on per patient basis, they want more no of patients for their payment, by which patient history, clinical examination are done more fastly, leading to poor quality of Health service, which can be greatly improved by payment to them on Salary basis.

What True National Health Care Reform Must Accomplish

September 2, 2009

Analysis by: GLG Expert Contributor

Analysis of:Bending the Curve:Effective Steps to Address Long-Term Health Care Spending Growth | www.brookings.edu

With so much of the spotlight the past month on "death panels" and other myths of health care reform, the more prosaic (but ultimately most significant) goals and objectives of reform have been lost amongst the cacophony. Ten undisputed national experts of various stripes across the bipartisan political spectrum have tried to bring us all back to a more cool headed reality as we enter the momentous make or break Autumn period for national health care reform.

Hospitals Must Upgrade Their Data Centers for Electronic Medical Record Surge

August 28, 2009

Analysis by: GLG Expert Contributor

Analysis of:Hospitals Update Data Centers | www.healthdatamanagement.com

The whole point of the Health Information Technology Economic and Clinical Health (HITECH) portion of the Economic Stimulus Law is to improve the quality, safety and efficiency of care delivery through the freer exchange of electronic patient information among treating practitioners. However, if hospitals' current data centers can't handle the inevitable great increase in data, the federal government's outlay of $36.5 billion to subsidize electronic health records will all be for naught.

Good move, keeping pace with the market demand.reta

August 27, 2009

Analysis by: GLG Expert Contributor

Analysis of:Ranbaxy forays into protein supplement market | economictimes.indiatimes.com

 Protein  and nutritional supplements have always had a good market value.  With people becoming more health conscious and a brand name like Ranbaxy, this product is likely to do very well.  And with no central agency in India, like the FDA in US, getting a go to market this product will be very easy.

Previous Page : 12345678910Next41 to 50 of 1031